loadpatents
Patent applications and USPTO patent grants for Gethin; David Morris.The latest application filed is for "substituted arylpyrazoles".
Patent | Date |
---|---|
Substituted arylpyrazoles Grant 8,084,486 - Billen , et al. December 27, 2 | 2011-12-27 |
Substituted Arylpyrazoles App 20110196011 - Billen; Denis ;   et al. | 2011-08-11 |
Substituted arylpyrazoles Grant 7,968,584 - Billen , et al. June 28, 2 | 2011-06-28 |
Substituted arylpyrazoles Grant 7,960,426 - Billen , et al. June 14, 2 | 2011-06-14 |
Substituted arylpyrazoles Grant 7,902,232 - Billen , et al. March 8, 2 | 2011-03-08 |
Substituted arylpyrazoles Grant 7,645,786 - Billen , et al. January 12, 2 | 2010-01-12 |
Substituted Arylpyrazoles App 20090312371 - Billen; Denis ;   et al. | 2009-12-17 |
Substituted Arylpyrazoles App 20090186924 - Billen; Denis ;   et al. | 2009-07-23 |
Substituted Arylpyrazoles App 20090137524 - Billen; Denis ;   et al. | 2009-05-28 |
Substituted arylpyrazoles Grant 7,538,134 - Billen , et al. May 26, 2 | 2009-05-26 |
Substituted arylpyrazoles Grant 7,514,464 - Billen , et al. April 7, 2 | 2009-04-07 |
Benzazepin-2(1h)-one Derivatives App 20080267942 - Boyle; Jessica ;   et al. | 2008-10-30 |
Substituted arylpyrazoles Grant 7,435,753 - Billen , et al. October 14, 2 | 2008-10-14 |
Substituted Arylpyrazoles App 20080176865 - Billen; Denis ;   et al. | 2008-07-24 |
Compounds App 20080161288 - Boyle; Jessica ;   et al. | 2008-07-03 |
Combination App 20080146643 - Billen; Denis ;   et al. | 2008-06-19 |
Benzazepin-2(1h)-one Derivatives App 20080103130 - Boyle; Jessica ;   et al. | 2008-05-01 |
Combination App 20070149464 - Billen; Denis ;   et al. | 2007-06-28 |
Substituted Arylpyrazoles App 20070149550 - Billen; Denis ;   et al. | 2007-06-28 |
Substituted arylpyrazoles App 20060287365 - Billen; Denis ;   et al. | 2006-12-21 |
Compounds useful in therapy Grant 7,012,083 - Gibson , et al. March 14, 2 | 2006-03-14 |
Substituted arylpyrazoles App 20060014802 - Billen; Denis ;   et al. | 2006-01-19 |
Substituted arylpyrazoles App 20050148649 - Billen, Denis ;   et al. | 2005-07-07 |
Compounds useful in therapy App 20050085456 - Gibson, Stephen Paul ;   et al. | 2005-04-21 |
Compounds useful in therapy Grant 6,812,236 - Gibson , et al. November 2, 2 | 2004-11-02 |
4-arylpiperidine derivatives for the treatment of pruritus Grant 6,750,231 - Gibson , et al. June 15, 2 | 2004-06-15 |
3-Azabicyclo[3.1.0]hexane derivatives useful in therapy App 20030207876 - Banks, Bernard Joseph ;   et al. | 2003-11-06 |
4-phenylpiperidines for the treatment of pruritic dermatoses Grant 6,610,711 - Armer , et al. August 26, 2 | 2003-08-26 |
Novel 4-phenylpiperidines for the treatment of pruritic dermatoses App 20030078282 - Armer, Richard Edward ;   et al. | 2003-04-24 |
New 4-arylpiperidine derivatives for the treatment of pruritus App 20030004340 - Gibson, Stephen Paul ;   et al. | 2003-01-02 |
Compounds useful in therapy App 20020099216 - Gibson, Stephen Paul ;   et al. | 2002-07-25 |
Compounds useful in therapy App 20020099214 - Gibson, Stephen Paul ;   et al. | 2002-07-25 |
3-azabicyclo[3.1.0]hexane derivatives useful in therapy App 20020025948 - Banks, Bernard Joseph ;   et al. | 2002-02-28 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.